INCREASING THE POTENCY OF THE VIRAL ANTI-CANCER AGENT REOLYSIN BY ADMINISTERING IT WITH VELCADE (BORTEZOMIB).

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Nawrocki,Steffan T

Funded by

WILLIAM & ELLA OWENS MED RSCH FOUNDATION

Research Start Date

01/01/2017

Status

Inactive

Clinical Care

Cancer

Bioscience Research Panel